Skip to main content
Submit a technology commercialization grant pre-proposal >>
Hide alert
About Us
History & Overview
Our Team
Research Services
Venture Analysts
Venture Center
Our Partners
Grants
Accelerating Innovation
Technology Commercialization
Postdoctoral Fellowships
Student Programs
Building the Innovation Ecosystem
Submit Phased Grant Pre-Proposal
Recent Grants
Startup Investments
Investing in Washington
Active Portfolio & Exits
Stories
News
Articles
Videos
Reports
Contact
Close
Keywords:
Search
Toggle Search
Toggle mobile menu
Juno’s leukemia drug may get speedier FDA review
Post navigation
←
Juno Therapeutics files for IPO, a year after founding, seeking $150M for cancer breakthroughs
Juno Therapeutics raises $265 million in IPO, closes high
→
Comments are closed.
About Us
History & Overview
Our Team
Research Services
Venture Analysts
Venture Center
Our Partners
Grants
Accelerating Innovation
Technology Commercialization
Postdoctoral Fellowships
Student Programs
Building the Innovation Ecosystem
Submit Phased Grant Pre-Proposal
Recent Grants
Startup Investments
Investing in Washington
Active Portfolio & Exits
Stories
News
Articles
Videos
Reports
Contact
Close menu
